Search results for: 'Receptors'

Cat No	Name	Description
KA4189	FLT3 (Ab-599) Antibody	The antiserum was produced against synthesized non-phosphopeptide derived from human FLT3 around the phosphorylation site of tyrosine 599 (Y-E-YP-D-L).
KA4188	FGFR1 (Ab-654) Antibody	The antiserum was produced against synthesized non-phosphopeptide derived from human FGFR1 around the phosphorylation site of tyrosine 654 (D-Y-YP-K-K).
KA4636	FGF Receptor 1 (Ab-154) Antibody	The antiserum was produced against synthesized non-phosphopeptide derived from human FGF Receptor 1 around the phosphorylation site of tyrosine 154 (A-P-Y-W-T).
KA4417	Estrogen Receptor-	The antiserum was produced against synthesized non-phosphopeptide derived from human Estrogen Receptor-
KA4627	Estrogen Receptor-	he antiserum was produced against synthesized non-phosphopeptide derived from human Estrogen Receptor-
KA4628	Estrogen Receptor-	The antiserum was produced against synthesized non-phosphopeptide derived from human Estrogen Receptor-
KA4629	Estrogen Receptor-	The antiserum was produced against synthesized non-phosphopeptide derived from human Estrogen Receptor-
KA4630	Estrogen Receptor-	The antiserum was produced against synthesized non-phosphopeptide derived from human Estrogen Receptor-
KA4817	Estrogen Receptor-	The antiserum was produced against synthesized non-phosphopeptide derived from human Estrogen Receptor-
KA4415	ErbB2 Antibody	The antiserum was produced against synthesized peptide derived from Internal of human ErbB2.
KA4414	Epo-R (Ab-368) Antibody	The antiserum was produced against synthesized non-phosphopeptide derived from human Epo-R around the phosphorylation site of tyrosine 368 (D-T-YP-L-V)
KA4412	EPHB1/2 (Ab-594/604) Antibody	The antiserum was produced against synthesized non-phosphopeptide derived from human EPHB1/2 around the phosphorylation site of tyrosine 594/604 (K-I-YP-I-D).
KA4622	elF4E (Ab-209) Antibody	The antiserum was produced against synthesized non-phosphopeptide derived from human elF4E around the phosphorylation site of serine 209 (S-G-SP-T-T).
KA4621	eIF2	The antiserum was produced against synthesized non-phosphopeptide derived from human eIF2
KA4781	EGFR (Ab-998) Antibody	The antiserum was produced against synthesized non-phosphopeptide derived from human EGFR around the phosphorylation site of tyrosine 998 (N-F-YP-R-A).
KA4620	EGFR (Ab-869) Antibody	The antiserum was produced against synthesized non-phosphopeptide derived from human EGFR around the phosphorylation site of tyrosine 869 (K-E-YP-H-A).
KA4101	EGFR (Ab-693) Antibody	The antiserum was produced against synthesized non-phosphopeptide derived from human EGFR around the phosphorylation site of threonine 693 (P-L-TP-P-S).
KA4100	EGFR (Ab-678) Antibody	The antiserum was produced against synthesized non-phosphopeptide derived from human EGFR around the phosphorylation site of threonine 678 (K-R-TP-L-R).
KA4619	EGFR (Ab-1197) Antibody	The antiserum was produced against synthesized non-phosphopeptide derived from human EGFR around the phosphorylation site of tyrosine 1197 (A-E-YP-L-R).
KA4618	EGFR (Ab-1110) Antibody	The antiserum was produced against synthesized non-phosphopeptide derived from human EGFR around the phosphorylation site of tyrosine 1110 (P-V-YP-H-N).